ABOUT US

Our Managerial Team

  • Calla Lin

    ——Co-founder & VP

    Entrepreneur with more than 30 years of business experience. He started to engage in international trade in the 1980s and invested in several international logistics companies. In recent years, he has participated in the investment of Aizhixing, K2 Longevity Technology and other large health companies. He has a mature business model and extensive network resources for the global market strategy layout.

  • XIANG Li

    ——Co-founder & CSO

    Master of Business Administration from Royal Roads University, Canada, Graduate of Medical and Health Industry Management from Peking University, established medical investment institutions in China in the early days, founded multiple medical institution brands, and operated and managed multiple brand hospitals. Participated in the investment of many domestic biological laboratories, and is also the founder of China's light luxury anti-aging skin care brand Placenta Cream.

  • C Colin Yang

    ——CTO|Chief Technology Officer

    With more than 20 years of industry experience, he is a basic transformation and application scientist. His professional fields include immunology, monoclonal antibody production, molecular biology protein biochemistry and analytical development, and he has excellent expertise in a wide range of technical fields. He has strong team leadership, good collaborative spirit and management skills, and is able to lead a multidisciplinary scientific research team.

  • Linda Wang

    ——CFO|Chief Financial Officer

    CPA in multiple states of the United States, with 25 years of professional background in tax planning and accounting management; worked for PricewaterhouseCoopers, one of the Big Four accounting firms; provides CFO consulting services and tax structures for enterprises, guides startups to obtain investment from venture capital and private equity funds, provides SEC10Q and 10K audits for enterprises to go public, and has rich experience in Sarbanes-Oxley 404 compliance.

Our Science Team

  • George Smoot

    2006 Nobel Prize winner in Physics
    Member of the National Academy of Sciences of the United States
    Father of cosmic embryology

    The winner of the 2006 Nobel Prize in Physics, he has published more than 600 articles and is known as the "Father of Cosmic Embryology". With his research and understanding of physics and various high-end instruments, Dr. Smoot is committed to integrating high-end physical technology into health and medical equipment products. Some of his medical products have been adopted by NASA and applied to NASA's space medical program. He was hired as a scientific advisor by the President of the United States.

  • Zhang Jiren

    Chairman of the Preventive Medicine Branch of the National Health Industry and Enterprise Management Association
    Chairman of the Thyroid Nodule Tumor Risk Prevention and Control Committee of the China Geriatric Care Association

    He has trained more than 100 doctoral and master's students, published more than 200 papers, and published 8 monographs. He is a recipient of the State Council's special allowance. He was awarded the title of "National 100 Young and Middle-aged Medical Scientists", applied for 72 patents, and has currently obtained 35 national science and technology invention patents.
    Currently, he has proposed new concepts of tumor targeted ablation therapy and anti-aging preventive medicine, and led the team to establish a human environmental carcinogen exposure detection and evaluation database and a human aging evaluation database.

  • Dean Felsher

    Professor of Oncology, Department of Medicine and Pathology, Stanford University
    Director of the Center for Translational Medicine, Stanford University, USA

    He has also participated in molecular imaging projects, tumor biology, and medical scientist training programs. He has trained 14 master's students and more than 20 postdoctoral researchers. He has participated in many research projects of the National Institutes of Health, covering topics such as clinical and molecular oncology, molecular carcinogenesis, molecular oncology, and nanomedicine.

  • Sherry Zhang

    Postdoctoral Fellow in Medicine and Biology at Harvard University
    Fortune 500 Thermo Fisher Scientific Scientist

    He has studied in Europe and the United States for more than 20 years, engaged in research on tumor gene molecular biology and research and development of anti-tumor antibody drugs. He is currently a scientist at Thermo Fisher Scientific, a Fortune 500 company. He has published many academic papers in famous academic journals at home and abroad and won many academic awards.
    Sherry Zhang has served as a senior medical consultant at Weikang Pharmaceuticals for more than ten years and has played a huge role in the company's development

Our Global Team

  • CEO Chen Kehui

    Qogori (Hong Kong) Company

  • CEO Liu Yousen

    Qogori (Guangzhou) Company

  • CEO He Xin

    Qorgori (Beijing) Company

  • CEO Li Zhendong

    Qorgori (Hainan) Company